154 related articles for article (PubMed ID: 36448068)
21. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
[TBL] [Abstract][Full Text] [Related]
22. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P; Robova H; Rob L; Zamecnik J
Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
[TBL] [Abstract][Full Text] [Related]
23. Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types.
Omori M; Hashi A; Nakazawa K; Yuminamochi T; Yamane T; Hirata S; Katoh R; Hoshi K
Am J Clin Pathol; 2007 Aug; 128(2):208-17. PubMed ID: 17638654
[TBL] [Abstract][Full Text] [Related]
24. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
25. Comparison of p16INK4a immunocytochemistry with the HPV polymerase chain reaction in predicting high grade cervical squamous intraepithelial lesions.
Indarti J; Fernando D
Asian Pac J Cancer Prev; 2013; 14(9):4989-92. PubMed ID: 24175764
[TBL] [Abstract][Full Text] [Related]
26. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
27. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of P16(INK4α) expression in Thinprep cervical specimens for the predication of high-grade cervical intraepithelial neoplasia].
Ma YY; Ye F; Chen XD; Qiu LQ; Lü WG; Xie X
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(43):3040-4. PubMed ID: 21211322
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Immunohistochemical Markers p16 and Ki-67 and Their Usefulness in the Diagnosis of Cervical Intraepithelial Neoplasms.
de Melo FL; Lancellotti CL; da Silva MA
Rev Bras Ginecol Obstet; 2016 Feb; 38(2):82-7. PubMed ID: 26883858
[TBL] [Abstract][Full Text] [Related]
30. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia.
Klaes R; Benner A; Friedrich T; Ridder R; Herrington S; Jenkins D; Kurman RJ; Schmidt D; Stoler M; von Knebel Doeberitz M
Am J Surg Pathol; 2002 Nov; 26(11):1389-99. PubMed ID: 12409715
[TBL] [Abstract][Full Text] [Related]
31. Expression of p16INK4A Protein in Cervical Intraepithelial Neoplasia and Invasive Carcinoma of Uterine Cervix.
Kishore V; Patil AG
J Clin Diagn Res; 2017 Sep; 11(9):EC17-EC20. PubMed ID: 29207716
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia.
Kruse AJ; Baak JP; Helliesen T; Kjellevold KH; Bol MG; Janssen EA
Am J Surg Pathol; 2002 Nov; 26(11):1501-7. PubMed ID: 12409727
[TBL] [Abstract][Full Text] [Related]
33. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
34. Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities.
Ekalaksananan T; Pientong C; Kongyingyoes B; Chaiwongkot A; Yuenyao P; Kleebkaow P; Kritpetcharat O; Evans MF
Asian Pac J Cancer Prev; 2011; 12(7):1777-83. PubMed ID: 22126564
[TBL] [Abstract][Full Text] [Related]
35. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
36. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
Qiao X; Bhuiya TA; Spitzer M
J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
[TBL] [Abstract][Full Text] [Related]
37. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
38. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
Horn LC; Reichert A; Oster A; Arndal SF; Trunk MJ; Ridder R; Rassmussen OF; Bjelkenkrantz K; Christiansen P; Eck M; Lorey T; Skovlund VR; Ruediger T; Schneider V; Schmidt D
Am J Surg Pathol; 2008 Apr; 32(4):502-12. PubMed ID: 18223479
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
[TBL] [Abstract][Full Text] [Related]
40. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions.
Garzetti GG; Ciavattini A; De Nictolis M; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Obstet Invest; 1996; 42(4):261-6. PubMed ID: 8979100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
